StemCells, Inc. Discontinues Batten Disease Program - Drugs.com MedNews
Links shared publicly online about this topic.
- 380total visits
StemCells, Inc. Discontinues Batten Disease Program - Drugs.com MedNews
From GlobeNewswire (April 8, 2011) StemCells, Inc. (Nasdaq STEM) today announced that it has discontinued its Phase Ib clinical trial in neuronal ceroid lipofus
View full resource at drugs.com
Tags: Disease and Condition, Drug, Clinical Trial, disease
Most Recently Shared on April 8, 2011 at 2:12 pm By:
StemCells, Inc. Discontinues Batten Disease Program: From GlobeNewswire (April 8, 2011) PALO ALTO, Calif.,... http://bit.ly/iekWAW #drug
Advertisement
